Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
In patients with chronic hepatitis C and cirrhosis or bridging fibrosis, 180 microg of peginterferon alfa-2a administered once weekly is significantly more effective than 3 mill...